AGN-199201 for the Treatment of Erythema With Rosacea
NCT01735201
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
357
Enrollment
INDUSTRY
Sponsor class
Conditions
Rosacea
Erythema
Interventions
DRUG:
AGN-199201 Dose A
DRUG:
AGN-199201 Dose B
DRUG:
AGN-199201 Dose C
DRUG:
AGN-199201 Vehicle
Sponsor
Allergan